And since Xanadu there has literally been 2 other clinical trials report positive results, being Xanahes and the XanaMIA Part A dosing study and the biomarker study going back to stored samples for Xanadu which showed very interesting cognitive improvements in patients with high pTau levels.
It is fine to reference the past as a cautionary tale, but if one tries to be rational and objective, Xanadu, like the movie, was a lifetime ago
- Forums
- ASX - By Stock
- ACW
- EU regulators reject Leqembi for Alzheimers
EU regulators reject Leqembi for Alzheimers, page-21
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $79.51M |
Open | High | Low | Value | Volume |
2.6¢ | 2.9¢ | 2.5¢ | $504.8K | 18.89M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 7589320 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 953289 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 7389320 | 0.026 |
32 | 7693725 | 0.025 |
27 | 7116982 | 0.024 |
19 | 5064711 | 0.023 |
15 | 6346717 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 953289 | 2 |
0.028 | 136128 | 1 |
0.029 | 522344 | 3 |
0.030 | 2710900 | 7 |
0.031 | 751771 | 3 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |